Glycolic Acid Plus Salicylic Acid in Treatment of Plane Wart
Efficacy of Glycolic Acid 15%Plus Salicylic Acid 2% Gel in Treatment of Plane Wart
1 other identifier
interventional
100
1 country
1
Brief Summary
To determine clinical efficacy of glycolic acid 15%plus salicylic acid 2% gel in treatment of Plane wart .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedFirst Submitted
Initial submission to the registry
November 21, 2023
CompletedFirst Posted
Study publicly available on registry
January 31, 2024
CompletedJanuary 31, 2024
November 1, 2023
10 months
November 21, 2023
January 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
treatment of plane wart
Evaluation of the efficacy of topical glycolic acid plus salicylic acid in treatment of plane wart. Response to treatment will be evaluated by the decrease in number or size of plane wart.
8weeks
Study Arms (1)
efficacy of glycolic acid 15%plus salicylic acid 2% gel in treatment of Plane wart .
OTHERInterventions
Prior to the procedure, patients will be instructed to avoid sun exposure during the treatment and to use broad spectrum sunscreen The treatment was started once daily over the entire face and maintained for two months. A fine layer of Glycolic Acid Plus Salicylic Acid face gel was applied on the whole surface where the warts were present, avoiding the eyelids and lips. In children 7 to 10 years of age, face gel was applied by their parents. Clinical controls were performed at Weeks 2, 4, 6, and 8.
Eligibility Criteria
You may not qualify if:
- Photosensitivity
- Scaring keloid
- Herpes simplex
- Pregnancy \& Lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut university
Asyut, 02 35315900, Egypt
Related Publications (1)
Rodriguez-Cerdeira C, Sanchez-Blanco E. Glycolic acid 15% plus salicylic acid 2%: a new therapeutic pearl for facial flat warts. J Clin Aesthet Dermatol. 2011 Sep;4(9):62-4.
PMID: 21938272RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident of Dermatology, Andrology and Venereology in Nag Hammadi General Hospirtal (Qena)
Study Record Dates
First Submitted
November 21, 2023
First Posted
January 31, 2024
Study Start
December 1, 2021
Primary Completion
September 30, 2022
Study Completion
December 30, 2022
Last Updated
January 31, 2024
Record last verified: 2023-11